Remuzzi G, Perico N

Language: Spanish
References: 20
Page: 75-76
PDF size: 89.77 Kb.

ABSTRACT

In 2008 the World Health Assembly endorsed the Global Noncommunicable Disease (NCD) Action Plan, based on growing evidence that NCDs have replaced communicable diseases as the most common cause of premature mortality worldwide. Priority was given to cardiovascular disease, cancer, diabetes and chronic respiratory disease since together they accounted for the major portion of global burden of NCDs and were the leading causes of death. The International Society of Nephrology (ISN), however, welcomed the Declaration of the High Level Meeting on NCDs a few years later in September 2011 stating that "the UN General Assembly recognizes that renal diseases pose a major health threat for many countries and share common risk factors and can benefit from common responses to noncommunicable diseases. ISN saw this important statement as a first step toward proper recognition of chronic kidney disease as a major NCD.

REFERENCES

1. World Health Organization. Preventing chronic diseases: a vital investment. Geneva: World Health Organization; 2005 Sep. 196 p.

2. The United Nations General Assembly. Political declaration of the highlevel meeting of the General Assembly on the prevention and control of non-communicable diseases [Internet]. New York: United Nations; 2012 Jan 24 [cited 2014 Feb 15]. Available from: http://www.who.int/nmh/events/un _ncd_summit2011/political_declaration_en.pdf

3. Feehally J. Chronic kidney disease: Health burden of kidney disease recognized by UN. Nat Rev Nephrol. 2011 Dec 6;8(1):12–3.

4. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2095–128.

5. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major non-communicable diseases. Kidney Int. 2011 Dec;80(12):1258–70.

6. Jha V, García G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013 Jul 20–26;382(9888):260–72.

7. Li PK, Chow KM, Matsuo S, Yang CW, Jha V, Becker G, et al. Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology (Carlton). 2011 Sep;16(7):633–41.

8. Jha V, Rathi M. Natural medicines causing acute kidney injury. Semin Nephrol. 2008 Jul;28(4):416–28.

9. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008 Dec 10;(12):1–23.

10. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008 Jul;74(2):158–69.

11. Guh JY, Chen HC, Tsai JF, Chuang LY. Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. Am J Kidney Dis. 2007 May;49(5):626–33.

12. Yang L, Su T, Li XM, Wang X, Cai SQ, Meng LQ, et al. Aristolochic acid nephropathy: variation in presentation and prognosis. Nephrol Dial Transplant. 2012 Jan;27(1):292–8.

13. Stefanovic V, Cukuranovic R, Miljkovic S, Marinkovic D, Toncheva D. Fifty years of Balkan endemic nephropathy: challenges of study using epidemiological method. Ren Fail. 2009;31(5):409–18.

14. Jayatilake N, Mendis S, Maheepala P, Mehta FR; CKDu National Research Project Team. Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country. BMC Nephrol. 2013 Aug 27;14:180.

15. Gooneratne IK, Ranaweera AK, Liyanarachchi NP, Gunawardane N, Lanerolle RD. Epidemiology of chronic kidney disease in a Sri Lankan population. Int J Diabetes Dev Ctries. 2008 Apr;28(2):60–4.

16. Chandrajith R, Nanayakkara S, Itai K, Aturaliya TN, Dissanayake CB, Abeysekera T, et al. Chronic kidney diseases of uncertain etiology (CKDue) in Sri Lanka: geographic distribution and environmental implications. Environ Geochem Health. 2011 Jun;33(3):267–78.

17. Wanigasuriya KP, Peiris-John RJ, Wickremasinghe R. Chronic kidney disease of unknown aetiology in Sri Lanka: is cadmium a likely cause? BMC Nephrol. 2011 Jul 5;12:32.

18. Wijkström J, Leiva R, Elinder CG, Leiva S, Trujillo Z, Trujillo L, et al. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis. 2013 Nov;62(5):908–18.

19. Wesseling C, Crowe J, Hogstdet C, Jakobsson K, Lucas R, Wegman DH, et al. Resolving the enigma of the mesoamerican nephropathy: a research workshop summary. Am J Kidney Dis. 2014 Mar;63(3):396–404.

20. Correa R, Wesseling C, Johnson RJ. CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am J Kidney Dis. 2014 Mar;63(3):506–20.